摘要
伦理审查中涉及人类遗传资源研究的项目,是否告知受试者研究结果是当前伦理审查关注的热点之一。人类遗传资源研究中意外检测结果的发生率高但其临床意义不大。通过对研究结果告知难题的正反两方面分析论证,认为基于研究者的专业责任、受试者的知情选择权等考虑,研究者默认选择将研究结果告知给有完全行为能力的受试者,在研究团队中需要有医学专业人士综合考虑多方面因素,提供咨询服务。
The research of human genetic resources in the ethical review is one of the hot topics in the current ethical review. The research results of human genetic resources have high incidence,but the clinical significance is not significant. Based on the results of the two sides to inform the problem analysis,professional responsibility,participants based on the right of informed choice and other considerations,the researchers will default results to give the subjects have full capacity,in the research team need to have medical professionals with comprehensive consideration of various factors provide consulting services.
出处
《中国临床药理学杂志》
CAS
CSCD
北大核心
2017年第3期271-275,共5页
The Chinese Journal of Clinical Pharmacology
基金
国家自然科学基金资助项目(81471040)
重庆市基础与前沿研究计划重点基金资助项目(cstc2015jcyj BX0138)
关键词
人类遗传资源研究
研究结果
告知
伦理审查
human genetic research
incidental findings
disclosure
research ethics